PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Low-molecular weight oligosaccharides from Gum tragacanth (Astragalus gossypinus) significantly decreased hyperglycemia, liver injury, and oxidative stress, while upregulating autophagy genes in male Wistar rats [PMID:36789034].
Addition of water-soluble, gel-forming fiber such as gum tragacanth to a mixed meal or glucose solution may reduce the expected rise in glucose concentration in both normal subjects and those with IDDM and NIDDM, though this requires large amounts of fiber [PMID:8384131].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32474076 (2020) — Gum Tragacanth: Structure, characteristics and applications in foods. · International journal of biological macromolecules
- 2.PMID: 33802011 (2021) — Gum Tragacanth (GT): A Versatile Biocompatible Material beyond Borders. · Molecules (Basel, Switzerland)
- 3.PMID: 37054856 (2023) — A review on tragacanth gum: A promising natural polysaccharide in drug delivery and cell therapy. · International journal of biological macromolecules
- 4.PMID: 12802529 (2003) — Exudate gums: occurrence, production, and applications. · Applied microbiology and biotechnology
- 5.PMID: 32003002 (2020) — Exudate gums: chemistry, properties and food applications - a review.